U.S. Markets closed

United Therapeutics Corporation (UTHR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
112.79+0.59 (+0.53%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 337.50%
S&P500 52-Week Change 3N/A
52 Week High 3127.79
52 Week Low 375.58
50-Day Moving Average 3116.77
200-Day Moving Average 3107.42

Share Statistics

Avg Vol (3 month) 3528.89k
Avg Vol (10 day) 3324.84k
Shares Outstanding 544.41M
Float 40.03M
% Held by Insiders 11.77%
% Held by Institutions 197.53%
Shares Short (Jul 14, 2020) 41.93M
Short Ratio (Jul 14, 2020) 43.45
Short % of Float (Jul 14, 2020) 44.97%
Short % of Shares Outstanding (Jul 14, 2020) 44.36%
Shares Short (prior month Jun 14, 2020) 43.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Sep 22, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 30.04%
Operating Margin (ttm)38.81%

Management Effectiveness

Return on Assets (ttm)8.55%
Return on Equity (ttm)15.21%

Income Statement

Revenue (ttm)1.43B
Revenue Per Share (ttm)32.60
Quarterly Revenue Growth (yoy)-3.10%
Gross Profit (ttm)1.33B
Net Income Avi to Common (ttm)429.8M
Diluted EPS (ttm)9.76
Quarterly Earnings Growth (yoy)-47.80%

Balance Sheet

Total Cash (mrq)1.56B
Total Cash Per Share (mrq)35.14
Total Debt (mrq)800M
Total Debt/Equity (mrq)25.86
Current Ratio (mrq)7.43
Book Value Per Share (mrq)69.75

Cash Flow Statement

Operating Cash Flow (ttm)666.5M
Levered Free Cash Flow (ttm)505.88M